{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:49:42Z","timestamp":1783486182191,"version":"3.55.0"},"reference-count":101,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,1]]},"abstract":"<jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>Genetic testing is increasingly used to diagnose or rule out thyroid cancer in indeterminate fine-needle aspirations. This review evaluates the usefulness of these methods with considerations of advantages and limitations.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Design<\/jats:title>\n<jats:p>Given the diagnostic problem associated with the increasing incidental detection of indeterminate thyroid nodules in the context of thyroid cancer overtreatment, we consider the conditions and respective necessary settings for the role of genetic testing to improve presurgical malignancy risk stratification.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We review diagnostic pathway requirements and commercially available molecular tests with their respective advantages and disadvantages and discuss the prerequisites required for local application and implementation including quality assurance for local ultrasound and cytopathology practices.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Recent improvements in available molecular diagnostic tests have brought high sensitivity and specificity in initial validation studies, but whether these promising results translate to other clinical settings depends on the quality of the local thyroid nodule diagnostic pathway.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Genetic testing can meaningfully improve presurgical malignancy risk assessment, but more work is needed to implement and use genetic testing effectively in local settings.<\/jats:p>\n<\/jats:sec>","DOI":"10.1530\/eje-21-1293","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T13:25:24Z","timestamp":1657200324000},"page":"R41-R52","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-7","source":"Crossref","is-referenced-by-count":24,"title":["DIAGNOSIS OF ENDOCRINE DISEASE: Usefulness of genetic testing of fine-needle aspirations for diagnosis of thyroid cancer"],"prefix":"10.1093","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1205-1553","authenticated-orcid":true,"given":"Paul","family":"Stewardson","sequence":"first","affiliation":[{"name":"Arnie Charbonneau Cancer Institute, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Eszlinger","sequence":"additional","affiliation":[{"name":"Departments of Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, University of Calgary Cumming School of Medicine, Universit\u00e4tsklinikum Halle, Institute of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1470-268X","authenticated-orcid":true,"given":"Ralf","family":"Paschke","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"bib1","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.2018.0898","article-title":"The diagnosis and management of thyroid nodules: a review","volume":"319","author":"Durante","year":"2018","unstructured":"Durante CGrani GLamartina LFiletti SMandel SJCooper DS. The diagnosis and management of thyroid nodules: a review. JAMA2018319914\u2013924. (https:\/\/doi.org\/10.1001\/jama.2018.0898)10.1001\/jama.2018.0898"},{"key":"bib2","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1210\/jc.2015-3100","article-title":"The influence of patient age on thyroid nodule formation, multinodularity, and thyroid cancer risk","volume":"100","author":"Kwong","year":"2015","unstructured":"Kwong NMedici MAngell TELiu XMarqusee ECibas ESKrane JFBarletta JAKim MILarsen PRThe influence of patient age on thyroid nodule formation, multinodularity, and thyroid cancer risk. Journal of Clinical Endocrinology and Metabolism20151004434\u20134440. (https:\/\/doi.org\/10.1210\/jc.2015-3100)10.1210\/jc.2015-3100"},{"key":"bib3","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1089\/105072503768499680","article-title":"The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area","volume":"13","author":"Volzke","year":"2003","unstructured":"Volzke HLudemann JRobinson DMSpieker KWSchwahn CKramer AJohn UMeng W. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid200313803\u2013810. (https:\/\/doi.org\/10.1089\/105072503768499680)10.1089\/105072503768499680"},{"key":"bib4","series-title":"European Journal of Clinical Investigation","article-title":"Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination","volume":"39","author":"Guth","year":"2009","unstructured":"Guth STu AJAberle JGalach ABamberger CM. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. European Journal of Clinical Investigation200939 7. (https:\/\/doi.org\/10.1111\/j.1365-2362.2009.02162.x)"},{"key":"bib5","series-title":"European Thyroid Journal","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000478927","article-title":"European Thyroid Association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS","volume":"6","author":"Russ","year":"2017","unstructured":"Russ GBonnema SJErdogan MFDurante CNgu RLeenhardt L. European Thyroid Association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS. European Thyroid Journal20176225\u2013237. (https:\/\/doi.org\/10.1159\/000478927)10.1159\/000478927"},{"key":"bib6","series-title":"New England Journal of Medicine","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1056\/NEJMp1604412","article-title":"Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis","volume":"375","author":"Vaccarella","year":"2016","unstructured":"Vaccarella SFranceschi SBray FWild CPPlummer MDal Maso L. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. New England Journal of Medicine2016375614\u2013617. (https:\/\/doi.org\/10.1056\/NEJMp1604412)10.1056\/NEJMp1604412"},{"key":"bib7","series-title":"Journal for Oto-Rhino-Laryngology and Its Related Specialties","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000345498","article-title":"Hemithyroidectomy: a meta-analysis of postoperative need for hormone replacement and complications","volume":"75","author":"Kandil","year":"2013","unstructured":"Kandil EKrishnan BNoureldine SIYao LTufano RP. Hemithyroidectomy: a meta-analysis of postoperative need for hormone replacement and complications. Journal for Oto-Rhino-Laryngology and Its Related Specialties2013756\u201317. (https:\/\/doi.org\/10.1159\/000345498)10.1159\/000345498"},{"key":"bib8","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1530\/EJE-18-0083","article-title":"Differences between ATA, AACE\/ACE\/AME and ACR TI-RADS ultrasound classifications performance in identifying cytological high-risk thyroid nodules","volume":"178","author":"Lauria Pantano","year":"2018","unstructured":"Lauria Pantano AMaddaloni EBriganti SIBeretta Anguissola GPerrella ETaffon CPalermo APozzilli PManfrini SCrescenzi A. Differences between ATA, AACE\/ACE\/AME and ACR TI-RADS ultrasound classifications performance in identifying cytological high-risk thyroid nodules. European Journal of Endocrinology2018178595\u2013603. (https:\/\/doi.org\/10.1530\/EJE-18-0083)10.1530\/EJE-18-0083"},{"key":"bib9","series-title":"Journal of Clinical Endocrinology and Metabolism","article-title":"Pheochromocytoma in children and adolescents with multiple endocrine neoplasia type 2B","volume":"104","author":"Makri","year":"2019","unstructured":"Makri AAkshintala SDerse-Anthony CDel Rivero JWidemann BStratakis CAGlod JLodish M. Pheochromocytoma in children and adolescents with multiple endocrine neoplasia type 2B. Journal of Clinical Endocrinology and Metabolism2019104 7\u201312. (https:\/\/doi.org\/10.1210\/jc.2018-00705)"},{"key":"bib10","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","unstructured":"Haugen BRAlexander EKBible KCDoherty GMMandel SJNikiforov YEPacini FRandolph GWSawka AMSchlumberger M2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid2016261\u2013133. (https:\/\/doi.org\/10.1089\/thy.2015.0020)10.1089\/thy.2015.0020"},{"key":"bib11","series-title":"Endocrine Practice","first-page":"622","article-title":"American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for clinical practice for the diagnosis and management of thyroid nodules","volume":"22","author":"Gharib","year":"2016","unstructured":"Gharib HPapini EGarber JRDuick DSHarrell RMHegedus LPaschke RValcavi RVitti P & American Association of Clinical Endocrinologists. American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocrine Practice201622622\u2013639. (https:\/\/doi.org\/10.4158\/EP161208.GL)"},{"key":"bib12","series-title":"Nuclear Medicine","first-page":"179","article-title":"Scintigraphically \u2018hot\u2019 thyroid nodules mainly go hand in hand with a normal TSH","volume":"50","author":"G\u00f6rges","year":"2011","unstructured":"G\u00f6rges RKandror TKuschnerus SZimny MPink RPalmedo HHach ARau HTanner CZaplatnikov KScintigraphically \u2018hot\u2019 thyroid nodules mainly go hand in hand with a normal TSH. Nuclear Medicine201150179\u2013188. (https:\/\/doi.org\/10.3413\/nukmed-0386-11-02)"},{"key":"bib13","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1089\/thy.2017.0167","article-title":"Low malignancy rates in fine-needle aspiration cytologies in a primary care setting in Germany","volume":"27","author":"Eszlinger","year":"2017","unstructured":"Eszlinger MUllmann MRuschenburg IBohme KGorke FFranzius CAdam SMolwitz TLandvogt CAmro BLow malignancy rates in fine-needle aspiration cytologies in a primary care setting in Germany. Thyroid2017271385\u20131392. (https:\/\/doi.org\/10.1089\/thy.2017.0167)10.1089\/thy.2017.0167"},{"key":"bib14","series-title":"European Journal of Surgical Oncology","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ejso.2019.10.004","article-title":"Quantifying the differences in surgical management of patients with definitive and indeterminate thyroid nodule cytology","volume":"46","author":"Stewart","year":"2020","unstructured":"Stewart RLeang YJBhatt CRGrodski SSerpell JLee JC. Quantifying the differences in surgical management of patients with definitive and indeterminate thyroid nodule cytology. European Journal of Surgical Oncology202046252\u2013257. (https:\/\/doi.org\/10.1016\/j.ejso.2019.10.004)10.1016\/j.ejso.2019.10.004"},{"key":"bib15","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1530\/EJE-12-0936","article-title":"Prospective evaluation of thyroid imaging reporting and data system on 4550 nodules with and without elastography","volume":"168","author":"Russ","year":"2013","unstructured":"Russ GRoyer BBigorgne CRouxel ABienvenu-Perrard MLeenhardt L. Prospective evaluation of thyroid imaging reporting and data system on 4550 nodules with and without elastography. European Journal of Endocrinology2013168649\u2013655. (https:\/\/doi.org\/10.1530\/EJE-12-0936)10.1530\/EJE-12-0936"},{"key":"bib16","series-title":"Endocrine","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12020-018-1634-0","article-title":"Thyroid nodule ultrasound reports in routine clinical practice provide insufficient information to estimate risk of malignancy","volume":"61","author":"Symonds","year":"2018","unstructured":"Symonds CJSeal PGhaznavi SCheung WYPaschke R. Thyroid nodule ultrasound reports in routine clinical practice provide insufficient information to estimate risk of malignancy. Endocrine201861303\u2013307. (https:\/\/doi.org\/10.1007\/s12020-018-1634-0)10.1007\/s12020-018-1634-0"},{"key":"bib17","series-title":"Journal of the American College of Radiology","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jacr.2017.01.046","article-title":"ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee","volume":"14","author":"Tessler","year":"2017","unstructured":"Tessler FNMiddleton WDGrant EGHoang JKBerland LLTeefey SACronan JJBeland MDDesser TSFrates MCACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. Journal of the American College of Radiology201714587\u2013595. (https:\/\/doi.org\/10.1016\/j.jacr.2017.01.046)10.1016\/j.jacr.2017.01.046"},{"key":"bib18","series-title":"Korean Journal of Radiology","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3348\/kjr.2016.17.3.370","article-title":"Ultrasonography diagnosis and imaging-based management of thyroid nodules: revised Korean Society of Thyroid Radiology consensus statement and recommendations","volume":"17","author":"Shin","year":"2016","unstructured":"Shin JHBaek JHChung JHa EJKim JHLee YHLim HKMoon WJNa DGPark JSUltrasonography diagnosis and imaging-based management of thyroid nodules: revised Korean Society of Thyroid Radiology consensus statement and recommendations. Korean Journal of Radiology201617370\u2013395. (https:\/\/doi.org\/10.3348\/kjr.2016.17.3.370)10.3348\/kjr.2016.17.3.370"},{"key":"bib19","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1089\/thy.2020.0090","article-title":"Thyroid nodules and real estate: location matters","volume":"30","author":"Tessler","year":"2020","unstructured":"Tessler FNThyroid nodules and real estate: location matters. Thyroid202030349\u2013350. (https:\/\/doi.org\/10.1089\/thy.2020.0090)10.1089\/thy.2020.0090"},{"key":"bib20","series-title":"Endocrine Practice","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.eprac.2021.04.007","article-title":"American Association of Clinical Endocrinology (AACE) and Associazione Medici endocrinologi (AME) thyroid nodule algorithmic tool endocrine practice","volume":"27","author":"Garber","year":"2021","unstructured":"Garber JAmerican Association of Clinical Endocrinology (AACE) and Associazione Medici endocrinologi (AME) thyroid nodule algorithmic tool endocrine practice. Endocrine Practice202127649\u2013660. (https:\/\/doi.org\/10.1016\/j.eprac.2021.04.007)10.1016\/j.eprac.2021.04.007"},{"key":"bib21","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1089\/thy.2017.0500","article-title":"The 2017 Bethesda system for reporting thyroid cytopathology","volume":"27","author":"Cibas","year":"2017","unstructured":"Cibas ESAli SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid2017271341\u20131346. (https:\/\/doi.org\/10.1089\/thy.2017.0500)10.1089\/thy.2017.0500"},{"key":"bib22","series-title":"Cancer Cytopathology","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/cncy.21517","article-title":"Thyroid FNA: international perspectives from the European Congress of Cytopathology \u2013 can we cross the bridge of classifications?","volume":"123","author":"Rossi","year":"2015","unstructured":"Rossi EDPusztaszeri MSchmitt FBongiovanni MChandra AFaquin WC. Thyroid FNA: international perspectives from the European Congress of Cytopathology \u2013 can we cross the bridge of classifications?Cancer Cytopathology2015123207\u2013211. (https:\/\/doi.org\/10.1002\/cncy.21517)10.1002\/cncy.21517"},{"key":"bib23","series-title":"Cytopathology","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/cyt.12226","article-title":"Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience","volume":"26","author":"Bongiovanni","year":"2015","unstructured":"Bongiovanni MMolinari FEszlinger MPaschke RBarizzi JMerlo EGiovanella LFasolini FCattaneo FRamelli FLaser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience. Cytopathology201526288\u2013296. (https:\/\/doi.org\/10.1111\/cyt.12226)10.1111\/cyt.12226"},{"key":"bib24","series-title":"Nature Reviews: Endocrinology","article-title":"Molecular profiling of thyroid nodule fine-needle aspiration cytology","volume":"13","author":"Eszlinger","year":"2017","unstructured":"Eszlinger MLau LGhaznavi SSymonds CChandarana SPKhalil MPaschke R. Molecular profiling of thyroid nodule fine-needle aspiration cytology. Nature Reviews: Endocrinology201713 415\u2013424. (https:\/\/doi.org\/10.1038\/nrendo.2017.24)"},{"key":"bib25","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1089\/thy.2010.0243","article-title":"A large multicenter correlation study of thyroid nodule cytopathology and histopathology","volume":"21","author":"Wang","year":"2011","unstructured":"Wang CCFriedman LKennedy GCWang HKebebew ESteward DLZeiger MAWestra WHWang YKhanafshar EA large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid201121243\u2013251. (https:\/\/doi.org\/10.1089\/thy.2010.0243)10.1089\/thy.2010.0243"},{"key":"bib26","series-title":"Acta Cytologica","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000521562","article-title":"Accuracy of thyroid fine needle aspiration cytology: a cyto-histologic correlation study in an integrated Canadian health care region with centralized pathology service","volume":"66","author":"Ghaznavi","year":"2022","unstructured":"Ghaznavi SAClayton HEszlinger MKhalil MSymonds CJPaschke R. Accuracy of thyroid fine needle aspiration cytology: a cyto-histologic correlation study in an integrated Canadian health care region with centralized pathology service. Acta Cytologica202266171\u2013178. (https:\/\/doi.org\/10.1159\/000521562)10.1159\/000521562"},{"key":"bib27","series-title":"Diagnostic Cytopathology","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/dc.21820","article-title":"Clinical impact of second opinion in thyroid fine needle aspiration cytology (FNAC): a study of 922 interinstitutional consultations","volume":"40","author":"Bajaj","year":"2012","unstructured":"Bajaj JMorgenstern NSugrue CWasserman JWasserman P. Clinical impact of second opinion in thyroid fine needle aspiration cytology (FNAC): a study of 922 interinstitutional consultations. Diagnostic Cytopathology201240422\u2013429. (https:\/\/doi.org\/10.1002\/dc.21820)10.1002\/dc.21820"},{"key":"bib28","series-title":"JAMA Surgery","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamasurg.2018.1153","article-title":"Performance of a genomic sequencing classifier for the preoperative diagnosis of cytologically indeterminate thyroid nodules","volume":"153","author":"Patel","year":"2018","unstructured":"Patel KNAngell TEBabiarz JBarth NMBlevins TDuh QYGhossein RAHarrell RMHuang JKennedy GCPerformance of a genomic sequencing classifier for the preoperative diagnosis of cytologically indeterminate thyroid nodules. JAMA Surgery2018153817\u2013824. (https:\/\/doi.org\/10.1001\/jamasurg.2018.1153)10.1001\/jamasurg.2018.1153"},{"key":"bib29","series-title":"JAMA Oncology","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1001\/jamaoncol.2018.4616","article-title":"Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: a prospective blinded multicenter study","volume":"5","author":"Steward","year":"2019","unstructured":"Steward DLCarty SESippel RSYang SPSosa JASipos JAFigge JJMandel SHaugen BRBurman KDPerformance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: a prospective blinded multicenter study. JAMA Oncology20195204\u2013212. (https:\/\/doi.org\/10.1001\/jamaoncol.2018.4616)10.1001\/jamaoncol.2018.4616"},{"key":"bib30","series-title":"Diagnostic Cytopathology","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/dc.24564","article-title":"Multiplatform molecular test performance in indeterminate thyroid nodules","volume":"48","author":"Lupo","year":"2020","unstructured":"Lupo MAWalts AESistrunk JWGiordano TJSadow PMMassoll NCampbell RJackson SAToney NNarick CMMultiplatform molecular test performance in indeterminate thyroid nodules. Diagnostic Cytopathology2020481254\u20131264. (https:\/\/doi.org\/10.1002\/dc.24564)10.1002\/dc.24564"},{"key":"bib31","series-title":"Journal of the American Society of Cytopathology","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jasc.2020.02.002","article-title":"Clinical performance of multiplatform mutation panel and microRNA risk classifier in indeterminate thyroid nodules","volume":"9","author":"Sistrunk","year":"2020","unstructured":"Sistrunk JWShifrin AFrager MBardales RHThomas JFishman NGoldberg PGuttler RGrant E. Clinical performance of multiplatform mutation panel and microRNA risk classifier in indeterminate thyroid nodules. Journal of the American Society of Cytopathology20209232\u2013241. (https:\/\/doi.org\/10.1016\/j.jasc.2020.02.002)10.1016\/j.jasc.2020.02.002"},{"key":"bib32","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1089\/thy.2019.0490","article-title":"A thyroid genetic classifier correctly predicts benign nodules with indeterminate cytology: two independent, multicenter, prospective validation trials","volume":"30","author":"Zafereo","year":"2020","unstructured":"Zafereo MMcIver BVargas-Salas SDominguez JMSteward DLHolsinger FCKandil EWilliams MCruz FLoyola SA thyroid genetic classifier correctly predicts benign nodules with indeterminate cytology: two independent, multicenter, prospective validation trials. Thyroid202030704\u2013712. (https:\/\/doi.org\/10.1089\/thy.2019.0490)10.1089\/thy.2019.0490"},{"key":"bib33","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1089\/thy.2019.0191","article-title":"ThyroSeq v2 testing: impact on cytologic diagnosis, management, and cost of care in patients with thyroid nodule","volume":"30","author":"Fazeli","year":"2020","unstructured":"Fazeli SRZehr BAmraei RToraldo GGuan HKindelberger DLee SCerda S. ThyroSeq v2 testing: impact on cytologic diagnosis, management, and cost of care in patients with thyroid nodule. Thyroid2020301528\u20131534. (https:\/\/doi.org\/10.1089\/thy.2019.0191)10.1089\/thy.2019.0191"},{"key":"bib34","series-title":"Cancer Cytopathology","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/cncy.21993","article-title":"Molecular testing for indeterminate thyroid nodules: performance of the Afirma gene expression classifier and ThyroSeq panel","volume":"126","author":"Jug","year":"2018","unstructured":"Jug RCDatto MBJiang XS. Molecular testing for indeterminate thyroid nodules: performance of the Afirma gene expression classifier and ThyroSeq panel. Cancer Cytopathology2018126471\u2013480. (https:\/\/doi.org\/10.1002\/cncy.21993)10.1002\/cncy.21993"},{"key":"bib35","series-title":"JAMA Otolaryngology: Head and Neck Surgery","first-page":"783","article-title":"Comparison of postmarketing findings vs the initial clinical validation findings of a thyroid nodule gene expression classifier: a systematic review and meta-analysis","volume":"145","author":"Valderrabano","year":"2019","unstructured":"Valderrabano PHallanger-Johnson JEThapa RWang XMcIver B. Comparison of postmarketing findings vs the initial clinical validation findings of a thyroid nodule gene expression classifier: a systematic review and meta-analysis. JAMA Otolaryngology: Head and Neck Surgery2019145783\u2013792. (https:\/\/doi.org\/10.1001\/jamaoto.2019.1449)"},{"key":"bib36","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1089\/thy.2018.0779","article-title":"Molecular testing versus diagnostic lobectomy in Bethesda III\/IV thyroid nodules: a cost-effectiveness analysis","volume":"29","author":"Nicholson","year":"2019","unstructured":"Nicholson KJRoberts MSMcCoy KLCarty SEYip L. Molecular testing versus diagnostic lobectomy in Bethesda III\/IV thyroid nodules: a cost-effectiveness analysis. Thyroid2019291237\u20131243. (https:\/\/doi.org\/10.1089\/thy.2018.0779)10.1089\/thy.2018.0779"},{"key":"bib37","series-title":"Journal of Clinical Pathology","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/jclinpath-2016-204089","article-title":"Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears","volume":"70","author":"Lithwick-Yanai","year":"2017","unstructured":"Lithwick-Yanai GDromi NShtabsky AMorgenstern SStrenov YFeinmesser MKravtsov VLeon MEHajd\u00fach MAli SZMulticentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears. Journal of Clinical Pathology201770500\u2013507. (https:\/\/doi.org\/10.1136\/jclinpath-2016-204089)10.1136\/jclinpath-2016-204089"},{"key":"bib38","series-title":"European Thyroid Journal","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000468519","article-title":"European Thyroid Association guidelines regarding thyroid nodule molecular fine-needle aspiration cytology diagnostics","volume":"6","author":"Paschke","year":"2017","unstructured":"Paschke RCantara SCrescenzi AJarzab BMusholt TJ Sobrinho Simoes MEuropean Thyroid Association guidelines regarding thyroid nodule molecular fine-needle aspiration cytology diagnostics. European Thyroid Journal20176115\u2013129. (https:\/\/doi.org\/10.1159\/000468519)10.1159\/000468519"},{"key":"bib39","series-title":"Annals of Surgery","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1097\/SLA.0000000000003580","article-title":"The American Association of Endocrine Surgeons guidelines for the definitive surgical management of thyroid disease in adults","volume":"271","author":"Patel","year":"2020","unstructured":"Patel KNYip LLubitz CCGrubbs EGMiller BSShen WAngelos PChen HDoherty GMFahey TJIIIThe American Association of Endocrine Surgeons guidelines for the definitive surgical management of thyroid disease in adults. Annals of Surgery2020271e21\u2013e93. (https:\/\/doi.org\/10.1097\/SLA.0000000000003580)10.1097\/SLA.0000000000003580"},{"key":"bib40","series-title":"Canadian Cancer Statistics 2021","year":"2021","unstructured":"Canadian Cancer Statistics Advisory Committee in Collaboration with the Canadian Cancer Society SCatPHAoC. Canadian Cancer Statistics 2021. Canadian Cancer Society, 2021."},{"key":"bib41","series-title":"Diagnostic Cytopathology","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/dc.24765","article-title":"Performance of Afirma genomic sequencing classifier vs gene expression classifier in Bethesda category III thyroid nodules: an institutional experience","volume":"49","author":"Zhang","year":"2021","unstructured":"Zhang LSmola BLew MPang JCantley RPantanowitz LHeider AJing X. Performance of Afirma genomic sequencing classifier vs gene expression classifier in Bethesda category III thyroid nodules: an institutional experience. Diagnostic Cytopathology202149921\u2013927. (https:\/\/doi.org\/10.1002\/dc.24765)10.1002\/dc.24765"},{"key":"bib42","series-title":"Endocrine-Related Cancer","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1530\/ERC-16-0512","article-title":"Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology","volume":"24","author":"Valderrabano","year":"2017","unstructured":"Valderrabano PKhazai LLeon METhompson ZJMa ZChung CHHallanger-Johnson JEOtto KJRogers KDCenteno BAEvaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology. Endocrine-Related Cancer201724127\u2013136. (https:\/\/doi.org\/10.1530\/ERC-16-0512)10.1530\/ERC-16-0512"},{"key":"bib43","series-title":"Surgery","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.surg.2018.04.062","article-title":"Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodules","volume":"165","author":"Marcadis","year":"2019","unstructured":"Marcadis ARValderrabano PHo ASTepe JSwartzwelder CEByrd SSacks WLUntch BRShaha ARXu BInterinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodules. Surgery201916517\u201324. (https:\/\/doi.org\/10.1016\/j.surg.2018.04.062)10.1016\/j.surg.2018.04.062"},{"key":"bib44","series-title":"JAMA Oncology","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jamaoncol.2020.5935","article-title":"Effectiveness of molecular testing techniques for diagnosis of indeterminate thyroid nodules: a randomized clinical trial","volume":"7","author":"Livhits","year":"2021","unstructured":"Livhits MJZhu CYKuo EJNguyen DTKim JTseng CHLeung AMRao JLevin MDouek MLEffectiveness of molecular testing techniques for diagnosis of indeterminate thyroid nodules: a randomized clinical trial. JAMA Oncology2021770\u201377. (https:\/\/doi.org\/10.1001\/jamaoncol.2020.5935)10.1001\/jamaoncol.2020.5935"},{"key":"bib45","series-title":"Journal of Clinical Pathology","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/jclinpath-2021-207429","article-title":"Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel","volume":"75","author":"Sgariglia","year":"2022","unstructured":"Sgariglia RNacchio MMigliatico IVigliar EMalapelle UPisapia PDe Luca CIaccarino ASalvatore DMasone SMoving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel. Journal of Clinical Pathology202275465\u2013471. (https:\/\/doi.org\/10.1136\/jclinpath-2021-207429)10.1136\/jclinpath-2021-207429"},{"key":"bib46","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1089\/thy.2018.0254","article-title":"Molecular classification of thyroid nodules with indeterminate cytology: development and validation of a highly sensitive and specific new miRNA-based classifier test using fine-needle aspiration smear slides","volume":"28","author":"Santos","year":"2018","unstructured":"Santos MTDBuzolin ALGama RRSilva ECADDufloth RMFigueiredo DLACarvalho AL. Molecular classification of thyroid nodules with indeterminate cytology: development and validation of a highly sensitive and specific new miRNA-based classifier test using fine-needle aspiration smear slides. Thyroid2018281618\u20131626. (https:\/\/doi.org\/10.1089\/thy.2018.0254)10.1089\/thy.2018.0254"},{"key":"bib47","series-title":"Endocrine","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s12020-020-02271-y","article-title":"Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodules","volume":"68","author":"Sponziello","year":"2020","unstructured":"Sponziello MBrunelli CVerrienti AGrani GPecce VAbballe LRamundo VDamante GRusso DLombardi CPPerformance of a dual-component molecular assay in cytologically indeterminate thyroid nodules. Endocrine202068458\u2013465. (https:\/\/doi.org\/10.1007\/s12020-020-02271-y)10.1007\/s12020-020-02271-y"},{"key":"bib48","series-title":"Journal of Clinical Pathology","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/jclinpath-2020-206445","article-title":"Preoperative detection of malignancy in fine-needle aspiration cytology (FNAC) smears with indeterminate cytology (Bethesda III, IV) by a combined molecular classifier","volume":"73","author":"Titov","year":"2020","unstructured":"Titov SDemenkov PSLukyanov SASergiyko SVKatanyan GAVeryaskina YAIvanov MK. Preoperative detection of malignancy in fine-needle aspiration cytology (FNAC) smears with indeterminate cytology (Bethesda III, IV) by a combined molecular classifier. Journal of Clinical Pathology202073722\u2013727. (https:\/\/doi.org\/10.1136\/jclinpath-2020-206445)10.1136\/jclinpath-2020-206445"},{"key":"bib49","series-title":"Surgery","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.surg.2020.04.004","article-title":"Malignancy is in the eye of the beholder: pathologic diagnosis of challenging follicular neoplasms in the era of noninvasive follicular thyroid neoplasms with papillary-like nuclear features and immunohistochemical and molecular adjuncts","volume":"169","author":"Craig","year":"2021","unstructured":"Craig SKhalil MEszlinger MItani DKoebel MKoro KMinoo POgilvie TStewardson PTeman CMalignancy is in the eye of the beholder: pathologic diagnosis of challenging follicular neoplasms in the era of noninvasive follicular thyroid neoplasms with papillary-like nuclear features and immunohistochemical and molecular adjuncts. Surgery202116922\u201326. (https:\/\/doi.org\/10.1016\/j.surg.2020.04.004)10.1016\/j.surg.2020.04.004"},{"key":"bib50","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1089\/thy.2018.0339","article-title":"Impact of mutation density and heterogeneity on papillary thyroid cancer clinical features and remission probability","volume":"29","author":"Colombo","year":"2019","unstructured":"Colombo CMuzza MProverbio MCTosi DSoranna DPesenti CRossi SCirello VDe Leo SFusco NImpact of mutation density and heterogeneity on papillary thyroid cancer clinical features and remission probability. Thyroid201929237\u2013251. (https:\/\/doi.org\/10.1089\/thy.2018.0339)10.1089\/thy.2018.0339"},{"key":"bib51","series-title":"European Thyroid Journal","first-page":"e210061","article-title":"Systematic population-based identification of NTRK and RET fusion-positive thyroid cancers","volume":"11","author":"Eszlinger","year":"2022","unstructured":"Eszlinger MStewardson PMcIntyre JBBox AKhalil MHyrcza MKoro KRuether DWu JPaschke R. Systematic population-based identification of NTRK and RET fusion-positive thyroid cancers. European Thyroid Journal202211e210061. (https:\/\/doi.org\/10.1530\/ETJ-21-0061)"},{"key":"bib52","series-title":"Archives of Pathology and Laboratory Medicine","doi-asserted-by":"publisher","first-page":"446","DOI":"10.5858\/arpa.2017-0174-RA","article-title":"Update on molecular testing for cytologically indeterminate thyroid nodules","volume":"142","author":"Nishino","year":"2018","unstructured":"Nishino MNikiforova M. Update on molecular testing for cytologically indeterminate thyroid nodules. Archives of Pathology and Laboratory Medicine2018142446\u2013457. (https:\/\/doi.org\/10.5858\/arpa.2017-0174-RA)10.5858\/arpa.2017-0174-RA"},{"key":"bib53","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1089\/thy.2008.0425","article-title":"Thyroid fine-needle aspiration biopsy: variability in reporting","volume":"19","author":"Lewis","year":"2009","unstructured":"Lewis CMChang KPPitman MFaquin WCRandolph GW. Thyroid fine-needle aspiration biopsy: variability in reporting. Thyroid200919717\u2013723. (https:\/\/doi.org\/10.1089\/thy.2008.0425)10.1089\/thy.2008.0425"},{"key":"bib54","series-title":"Otolaryngology: Head and Neck Surgery","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1177\/0194599820911718","article-title":"Long-term outcomes of thyroid nodule AFIRMA GEC testing and literature review: an institutional experience","volume":"162","author":"Vora","year":"2020","unstructured":"Vora AHolt SHaque WLingvay I. Long-term outcomes of thyroid nodule AFIRMA GEC testing and literature review: an institutional experience. Otolaryngology: Head and Neck Surgery2020162634\u2013640. (https:\/\/doi.org\/10.1177\/0194599820911718)10.1177\/0194599820911718"},{"key":"bib55","series-title":"Acta Cytologica","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000521562","article-title":"Accuracy of thyroid fine-needle aspiration cytology: a cyto-histologic correlation study in an integrated Canadian health care region with centralized pathology service","volume":"66","author":"Ghaznavi","year":"2022","unstructured":"Ghaznavi SAClayton HEszlinger MKhalil MSymonds CJPaschke R. Accuracy of thyroid fine-needle aspiration cytology: a cyto-histologic correlation study in an integrated Canadian health care region with centralized pathology service. Acta Cytologica202266171\u2013178. (https:\/\/doi.org\/10.1159\/000521562)10.1159\/000521562"},{"key":"bib56","series-title":"Journal of Molecular Pathology","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/jmp2030020","article-title":"Molecular testing of thyroid fine-needle aspiration: local issues and solutions. An interventional cytopathologist perspective","volume":"2","author":"Bellevicine","year":"2021","unstructured":"Bellevicine CSgariglia RNacchio MDe Luca CPisapia PPepe FTroncone G. Molecular testing of thyroid fine-needle aspiration: local issues and solutions. An interventional cytopathologist perspective. Journal of Molecular Pathology20212233\u2013240. (https:\/\/doi.org\/10.3390\/jmp2030020)10.3390\/jmp2030020"},{"key":"bib57","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1089\/thy.2020.0969","article-title":"Repeat fine needle aspiration cytology refines the selection of thyroid nodules for afirma gene expression classifier testing","volume":"31","author":"Nishino","year":"2021","unstructured":"Nishino MMateo RKilim HFeldman AElliott AShen CHasselgren POWang HHartzband PHennessey JV. Repeat fine needle aspiration cytology refines the selection of thyroid nodules for afirma gene expression classifier testing. Thyroid2021311253\u20131263. (https:\/\/doi.org\/10.1089\/thy.2020.0969)10.1089\/thy.2020.0969"},{"key":"bib58","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1089\/thy.2019.0783","article-title":"Trends in the surgical management of known or suspected differentiated thyroid cancer at a single institution, 2010\u20132018","volume":"30","author":"Zhu","year":"2020","unstructured":"Zhu CYSha STseng CHYang SEOrr LELevin MWong CWLivhits MJRao JYeh MW. Trends in the surgical management of known or suspected differentiated thyroid cancer at a single institution, 2010\u20132018. Thyroid2020301639\u20131645. (https:\/\/doi.org\/10.1089\/thy.2019.0783)10.1089\/thy.2019.0783"},{"key":"bib59","series-title":"Head and Neck","first-page":"1812","article-title":"Impact of oncogene panel results on surgical management of cytologically indeterminate thyroid nodules","volume":"40","author":"Valderrabano","year":"2018","unstructured":"Valderrabano PKhazai LThompson ZJLeon MEOtto KJHallanger\u2010Johnson JEWadsworth JTChung CHCenteno BAMcIver B. Impact of oncogene panel results on surgical management of cytologically indeterminate thyroid nodules. Head and Neck2018401812\u20131823. (https:\/\/doi.org\/10.1002\/hed.25165)"},{"key":"bib60","series-title":"Cancer Control","first-page":"1073274817729231","article-title":"Evaluation and management of indeterminate thyroid nodules: the revolution of risk stratification beyond cytological diagnosis","volume":"24","author":"Valderrabano","year":"2017","unstructured":"Valderrabano PMcIver B. Evaluation and management of indeterminate thyroid nodules: the revolution of risk stratification beyond cytological diagnosis. Cancer Control2017241073274817729231. (https:\/\/doi.org\/10.1177\/1073274817729231)"},{"key":"bib61","series-title":"Endocrine-Related Cancer","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1530\/ERC-20-0511","article-title":"The thyroid risk score (TRS) for nodules with indeterminate cytology","volume":"28","author":"Colombo","year":"2021","unstructured":"Colombo CMuzza MPogliaghi GPalazzo SVannucchi GVicentini LPersani LGazzano GFugazzola L. The thyroid risk score (TRS) for nodules with indeterminate cytology. Endocrine-Related Cancer202128225\u2013235. (https:\/\/doi.org\/10.1530\/ERC-20-0511)10.1530\/ERC-20-0511"},{"key":"bib62","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ccell.2018.07.002","article-title":"Integrated genomic analysis of H\u00fcrthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes","volume":"34","author":"Ganly","year":"2018","unstructured":"Ganly IMakarov VDeraje SDong YReznik ESeshan VNanjangud GEng SBose PKuo FIntegrated genomic analysis of H\u00fcrthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes. Cancer Cell201834256\u2013270.e5. (https:\/\/doi.org\/10.1016\/j.ccell.2018.07.002)10.1016\/j.ccell.2018.07.002"},{"key":"bib63","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1089\/thy.2019.0088","article-title":"Short Review: Genomic alterations in H\u00fcrthle cell carcinoma","volume":"29","author":"Ganly","year":"2019","unstructured":"Ganly IMcFadden DG. Short Review: Genomic alterations in H\u00fcrthle cell carcinoma. Thyroid201929471\u2013479. (https:\/\/doi.org\/10.1089\/thy.2019.0088)10.1089\/thy.2019.0088"},{"key":"bib64","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ccell.2018.06.013","article-title":"Widespread chromosomal losses and mitochondrial DNA alterations as genetic drivers in H\u00fcrthle cell carcinoma","volume":"34","author":"Gopal","year":"2018","unstructured":"Gopal RKK\u00fcbler KCalvo SEPolak PLivitz DRosebrock DSadow PMCampbell BDonovan SEAmin SWidespread chromosomal losses and mitochondrial DNA alterations as genetic drivers in H\u00fcrthle cell carcinoma. Cancer Cell201834242.e5\u2013255.e5. (https:\/\/doi.org\/10.1016\/j.ccell.2018.06.013)10.1016\/j.ccell.2018.06.013"},{"key":"bib65","series-title":"Diagnostic Cytopathology","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/dc.24247","article-title":"H\u00fcrthle cell lesions on thyroid fine needle aspiration cytology: molecular and histologic correlation","volume":"47","author":"Schatz\u2010Siemers","year":"2019","unstructured":"Schatz\u2010Siemers NBrandler TCOweity TSun WHernandez ALevine P. H\u00fcrthle cell lesions on thyroid fine needle aspiration cytology: molecular and histologic correlation. Diagnostic Cytopathology201947977\u2013985. (https:\/\/doi.org\/10.1002\/dc.24247)10.1002\/dc.24247"},{"key":"bib66","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1089\/thy.2020.0021","article-title":"Letter to the editor: use of molecular diagnostic tests in thyroid nodules with h\u00fcrthle cell-dominant cytology","volume":"30","author":"Endo","year":"2020","unstructured":"Endo MNabhan FAngell TEHarrell RMNasr CWei SSipos JA. Letter to the editor: use of molecular diagnostic tests in thyroid nodules with h\u00fcrthle cell-dominant cytology. Thyroid2020301390\u20131392. (https:\/\/doi.org\/10.1089\/thy.2020.0021)10.1089\/thy.2020.0021"},{"key":"bib67","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1210\/jc.2011-3048","article-title":"Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies","volume":"97","author":"Yip","year":"2012","unstructured":"Yip LFarris CKabaker ASHodak SPNikiforova MNMcCoy KLStang MTSmith KJNikiforov YECarty SE. Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies. Journal of Clinical Endocrinology and Metabolism2012971905\u20131912. (https:\/\/doi.org\/10.1210\/jc.2011-3048)10.1210\/jc.2011-3048"},{"key":"bib68","series-title":"Surgery","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.surg.2015.05.035","article-title":"Effect of malignancy rates on cost-effectiveness of routine gene expression classifier testing for indeterminate thyroid nodules","volume":"159","author":"Wu","year":"2016","unstructured":"Wu JXLam RLevin MRao JSullivan PSYeh MW. Effect of malignancy rates on cost-effectiveness of routine gene expression classifier testing for indeterminate thyroid nodules. Surgery2016159118\u2013126. (https:\/\/doi.org\/10.1016\/j.surg.2015.05.035)10.1016\/j.surg.2015.05.035"},{"key":"bib69","series-title":"Otolaryngology: Head and Neck Surgery","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/0194599817725709","article-title":"Cost-effectiveness of gene expression classifier testing of indeterminate thyroid nodules utilizing a real cohort comparator","volume":"157","author":"Shapiro","year":"2017","unstructured":"Shapiro SPharaon MKellermeyer B. Cost-effectiveness of gene expression classifier testing of indeterminate thyroid nodules utilizing a real cohort comparator. Otolaryngology: Head and Neck Surgery2017157596\u2013601. (https:\/\/doi.org\/10.1177\/0194599817725709)10.1177\/0194599817725709"},{"key":"bib70","series-title":"Current Medical Research and Opinion","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1185\/03007995.2016.1166103","article-title":"Impact of a gene expression classifier on the long-term management of patients with cytologically indeterminate thyroid nodules","volume":"32","author":"Singer","year":"2016","unstructured":"Singer JHanna JWVisaria JGu TMcCoy MKloos RT. Impact of a gene expression classifier on the long-term management of patients with cytologically indeterminate thyroid nodules. Current Medical Research and Opinion2016321225\u20131232. (https:\/\/doi.org\/10.1185\/03007995.2016.1166103)10.1185\/03007995.2016.1166103"},{"key":"bib71","series-title":"Endocrine Practice","doi-asserted-by":"publisher","first-page":"780","DOI":"10.4158\/EP-2018-0212","article-title":"ThyroSeq\u00aeV2.0 molecular testing: a cost-effective approach for the evaluation of indeterminate thyroid nodules","volume":"24","author":"Rivas","year":"2018","unstructured":"Rivas AMNassar AZhang JCasler JDChindris AMSmallridge RBernet V. ThyroSeq\u00aeV2.0 molecular testing: a cost-effective approach for the evaluation of indeterminate thyroid nodules. Endocrine Practice201824780\u2013788. (https:\/\/doi.org\/10.4158\/EP-2018-0212)10.4158\/EP-2018-0212"},{"key":"bib72","series-title":"Value in Health","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.jval.2012.06.017","article-title":"Cost-effectiveness of using a molecular diagnostic test to improve preoperative diagnosis of thyroid cancer","volume":"15","author":"Najafzadeh","year":"2012","unstructured":"Najafzadeh MMarra CALynd LDWiseman SM. Cost-effectiveness of using a molecular diagnostic test to improve preoperative diagnosis of thyroid cancer. Value in Health2012151005\u20131013. (https:\/\/doi.org\/10.1016\/j.jval.2012.06.017)10.1016\/j.jval.2012.06.017"},{"key":"bib73","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"E1719","DOI":"10.1210\/jc.2011-0459","article-title":"Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules","volume":"96","author":"Li","year":"2011","unstructured":"Li HRobinson KAAnton BSaldanha IJLadenson PW. Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules. Journal of Clinical Endocrinology and Metabolism201196E1719\u2013E1726. (https:\/\/doi.org\/10.1210\/jc.2011-0459)10.1210\/jc.2011-0459"},{"key":"bib74","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1210\/jc.2014-1219","article-title":"Cost-effectiveness of molecular testing for thyroid nodules with atypia of undetermined significance cytology","volume":"99","author":"Lee","year":"2014","unstructured":"Lee LHow JTabah RJMitmaker EJ. Cost-effectiveness of molecular testing for thyroid nodules with atypia of undetermined significance cytology. Journal of Clinical Endocrinology and Metabolism2014992674\u20132682. (https:\/\/doi.org\/10.1210\/jc.2014-1219)10.1210\/jc.2014-1219"},{"key":"bib75","series-title":"JAMA Otolaryngology: Head and Neck Surgery","first-page":"845","article-title":"Molecular profiling of thyroid nodules \u2013 are these findings meaningful, or merely measurable?: a review","volume":"146","author":"Morris","year":"2020","unstructured":"Morris LGTMolecular profiling of thyroid nodules \u2013 are these findings meaningful, or merely measurable?: a review. JAMA Otolaryngology: Head and Neck Surgery2020146845\u2013850. (https:\/\/doi.org\/10.1001\/jamaoto.2020.1851)"},{"key":"bib76","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/cncr.33421","article-title":"Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: a matched case\u2010control study","volume":"127","author":"Yip","year":"2021","unstructured":"Yip LGooding WENikitski AWald AICarty SEKarslioglu\u2010French ESeethala RRZandberg DPFerris RLNikiforova MNRisk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: a matched case\u2010control study. Cancer20211271779\u20131787. (https:\/\/doi.org\/10.1002\/cncr.33421)10.1002\/cncr.33421"},{"key":"bib77","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/thy.2020.0307","article-title":"Limitations of detecting genetic variants from the RNA sequencing data in tissue and fine-needle aspiration samples","volume":"31","author":"Kaya","year":"2021","unstructured":"Kaya CDorsaint PMercurio SCampbell AMEng KWNikiforova MNElemento ONikiforov YESboner A. Limitations of detecting genetic variants from the RNA sequencing data in tissue and fine-needle aspiration samples. Thyroid202131589\u2013595. (https:\/\/doi.org\/10.1089\/thy.2020.0307)10.1089\/thy.2020.0307"},{"key":"bib78","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1210\/clinem\/dgab304","article-title":"Afirma genomic sequencing classifier and Xpression atlas molecular findings in consecutive Bethesda III-VI thyroid nodules","volume":"106","author":"Hu","year":"2021","unstructured":"Hu MIWaguespack SGDosiou CLadenson PWLivhits MJWirth LJSadow PMKrane JFStack BCZafereo MEAfirma genomic sequencing classifier and Xpression atlas molecular findings in consecutive Bethesda III-VI thyroid nodules. Journal of Clinical Endocrinology and Metabolism20211062198\u20132207. (https:\/\/doi.org\/10.1210\/clinem\/dgab304)10.1210\/clinem\/dgab304"},{"issue":"Supplement1","key":"bib79","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"A-1","DOI":"10.1089\/thy.2021.29115.abstracts","article-title":"September 30\u2013October 3, 2021 virtual","volume":"31","author":"Chiosea","year":"2021","unstructured":"Chiosea SHodak SYip LBaldwin CBaloch ZHannoush ZHaugen BJoseph LKargi AKhanafshar ESeptember 30\u2013October 3, 2021 virtual. Thyroid202131 (Supplement1) A-1\u2013A-114.10.1089\/thy.2021.29115.abstracts"},{"key":"bib80","series-title":"Frontiers in Oncology","doi-asserted-by":"publisher","first-page":"540238","DOI":"10.3389\/fonc.2020.540238","article-title":"The coexistence of genetic mutations in thyroid carcinoma predicts histopathological factors associated with a poor prognosis: a systematic review and network meta-analysis","volume":"10","author":"Zhao","year":"2020","unstructured":"Zhao LWang LJia XHu XPang PZhao SWang YWang JZhang YLyu Z. The coexistence of genetic mutations in thyroid carcinoma predicts histopathological factors associated with a poor prognosis: a systematic review and network meta-analysis. Frontiers in Oncology202010540238. (https:\/\/doi.org\/10.3389\/fonc.2020.540238)10.3389\/fonc.2020.540238"},{"key":"bib81","series-title":"Cancer Discovery","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1158\/2159-8290.CD-18-0606","article-title":"EIF1AX and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC","volume":"9","author":"Krishnamoorthy","year":"2019","unstructured":"Krishnamoorthy GPDavidson NRLeach SDZhao ZLowe SWLee GLanda INagarajah JSaqcena MSingh KEIF1AX and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC. Cancer Discovery20199264\u2013281. (https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0606)10.1158\/2159-8290.CD-18-0606"},{"key":"bib82","series-title":"Endocrine-Related Cancer","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1530\/ERC-15-0533","article-title":"Tert promoter mutations in thyroid cancer","volume":"23","author":"Liu","year":"2016","unstructured":"Liu RXing M. Tert promoter mutations in thyroid cancer. Endocrine-Related Cancer201623R143\u2013R155. (https:\/\/doi.org\/10.1530\/ERC-15-0533)10.1530\/ERC-15-0533"},{"key":"bib83","series-title":"Journal of Nuclear Medicine","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2967\/jnumed.116.180240","article-title":"Tert promoter mutation predicts radioiodine-refractory character in distant metastatic differentiated thyroid cancer","volume":"58","author":"Yang","year":"2017","unstructured":"Yang XLi JLi XLiang ZGao WLiang JCheng SLin Y. Tert promoter mutation predicts radioiodine-refractory character in distant metastatic differentiated thyroid cancer. Journal of Nuclear Medicine201758258\u2013265. (https:\/\/doi.org\/10.2967\/jnumed.116.180240)10.2967\/jnumed.116.180240"},{"key":"bib84","series-title":"Annals of Surgery","article-title":"Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients","volume":"262","author":"Yip","year":"2015","unstructured":"Yip LNikiforova MNYoo JYMcCoy KLStang MTArmstrong MJNicholson KJOhori NPCoyne CHodak SPTumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients. Annals of Surgery2015262 519\u2013525; discussion 524. (https:\/\/doi.org\/10.1097\/SLA.0000000000001420)"},{"key":"bib85","series-title":"Endocrine","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s12020-020-02531-x","article-title":"Impact of expert review of histological diagnosis of papillary and follicular thyroid cancer","volume":"72","author":"Hescot","year":"2021","unstructured":"Hescot SSheikh-Alard HKordahi MHartl DHadoux JTerroir MBreuskin IBaudin EScoazec JYSchlumberger MImpact of expert review of histological diagnosis of papillary and follicular thyroid cancer. Endocrine202172791\u2013797. (https:\/\/doi.org\/10.1007\/s12020-020-02531-x)10.1007\/s12020-020-02531-x"},{"key":"bib86","series-title":"WHO Classification of Tumours of Endocrine Organs","author":"Lloyd","year":"2017","unstructured":"Lloyd RVOsamura RYKl\u00f6ppel GRosai JBosman FTJaffe ESLakhani SROhgaki H. WHO Classification of Tumours of Endocrine Organs. International Agency for Research onCancer, 2017."},{"key":"bib87","series-title":"Endocrine Pathology","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12022-021-09665-2","article-title":"Molecular pathology of poorly differentiated and anaplastic thyroid cancer: what do pathologists need to know?","volume":"32","author":"Volante","year":"2021","unstructured":"Volante MLam AKPapotti MTallini G. Molecular pathology of poorly differentiated and anaplastic thyroid cancer: what do pathologists need to know?Endocrine Pathology20213263\u201376. (https:\/\/doi.org\/10.1007\/s12022-021-09665-2)10.1007\/s12022-021-09665-2"},{"key":"bib88","series-title":"Human Pathology","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/S0046-8177(03)00403-9","article-title":"Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma","volume":"34","author":"Franc","year":"2003","unstructured":"Franc BDe La Salmoni\u00e8re PLange FHoang CLouvel ADe Roquancourt AVild\u00e9 FHejblum GChevret SChastang C. Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. Human Pathology2003341092\u20131100. (https:\/\/doi.org\/10.1016\/s0046-8177(0300403-9)10.1016\/S0046-8177(03)00403-9"},{"key":"bib89","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1089\/thy.2014.0362","article-title":"Molecular testing of thyroid fine-needle aspirations improves presurgical diagnosis and supports the histologic identification of minimally invasive follicular thyroid carcinomas","volume":"25","author":"Eszlinger","year":"2015","unstructured":"Eszlinger MPiana SMoll AB\u00f6senberg EBisagni ACiarrocchi ARagazzi MPaschke R. Molecular testing of thyroid fine-needle aspirations improves presurgical diagnosis and supports the histologic identification of minimally invasive follicular thyroid carcinomas. Thyroid201525401\u2013409. (https:\/\/doi.org\/10.1089\/thy.2014.0362)10.1089\/thy.2014.0362"},{"key":"bib90","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1089\/thy.2019.0116","article-title":"Utilities of RAS mutations in preoperative fine needle biopsies for decision making for thyroid nodule management: results from a single-center prospective cohort","volume":"30","author":"Guan","year":"2020","unstructured":"Guan HToraldo GCerda SGodley FARao SRMcAneny DDoherty GBraverman LLee SL. Utilities of RAS mutations in preoperative fine needle biopsies for decision making for thyroid nodule management: results from a single-center prospective cohort. Thyroid202030536\u2013547. (https:\/\/doi.org\/10.1089\/thy.2019.0116)10.1089\/thy.2019.0116"},{"key":"bib91","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1089\/thy.2019.0278","article-title":"Molecular variants and their risks for malignancy in cytologically indeterminate thyroid nodules","volume":"29","author":"Goldner","year":"2019","unstructured":"Goldner WSAngell TEMcAdoo SLBabiarz JSadow PMNabhan FANasr CKloos RT. Molecular variants and their risks for malignancy in cytologically indeterminate thyroid nodules. Thyroid2019291594\u20131605. (https:\/\/doi.org\/10.1089\/thy.2019.0278)10.1089\/thy.2019.0278"},{"key":"bib92","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1089\/thy.2017.0635","article-title":"Heterogeneity in positive predictive value of RAS mutations in cytologically indeterminate thyroid nodules","volume":"28","author":"Nabhan","year":"2018","unstructured":"Nabhan FPorter KLupo MARandolph GWPatel KNKloos RT. Heterogeneity in positive predictive value of RAS mutations in cytologically indeterminate thyroid nodules. Thyroid201828729\u2013738. (https:\/\/doi.org\/10.1089\/thy.2017.0635)10.1089\/thy.2017.0635"},{"key":"bib93","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1089\/thy.2020.0148","article-title":"Thoughtful utilization of molecular testing in refining thyroid nodule risk assessment: do not throw out the baby","volume":"30","author":"Yip","year":"2020","unstructured":"Yip LThoughtful utilization of molecular testing in refining thyroid nodule risk assessment: do not throw out the baby. Thyroid202030474\u2013475. (https:\/\/doi.org\/10.1089\/thy.2020.0148)10.1089\/thy.2020.0148"},{"key":"bib94","series-title":"American Journal of Pathology","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0002-9440(10)64045-X","article-title":"\u03b2-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis","volume":"158","author":"Garcia-Rostan","year":"2001","unstructured":"Garcia-Rostan GCamp RLHerrero ACarcangiu MLRimm DLTallini G. \u03b2-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. American Journal of Pathology2001158987\u2013996. (https:\/\/doi.org\/10.1016\/s0002-9440(1064045-x)10.1016\/S0002-9440(10)64045-X"},{"key":"bib95","series-title":"Endocrine-Related Cancer","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1530\/ERC-21-0095","article-title":"Can TP53-mutant follicular adenoma be a precursor of anaplastic thyroid carcinoma?","volume":"28","author":"Nikitski","year":"2021","unstructured":"Nikitski AVNikiforova MNYip LKarslioglu-French ECarty SENikiforov YE. Can TP53-mutant follicular adenoma be a precursor of anaplastic thyroid carcinoma?Endocrine-Related Cancer202128621\u2013630. (https:\/\/doi.org\/10.1530\/ERC-21-0095)10.1530\/ERC-21-0095"},{"key":"bib96","series-title":"Cancer Research","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1158\/0008-5472.CAN-09-0727","article-title":"Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1","volume":"69","author":"Ricarte-Filho","year":"2009","unstructured":"Ricarte-Filho JCRyder MChitale DARivera MHeguy ALadanyi MJanakiraman MSolit DKnauf JATuttle RMMutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1. Cancer Research2009694885\u20134893. (https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-0727)10.1158\/0008-5472.CAN-09-0727"},{"key":"bib97","series-title":"Journal of Clinical Investigation","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1172\/JCI116385","article-title":"Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland","volume":"91","author":"Donghi","year":"1993","unstructured":"Donghi RLongoni APilotti SMichieli PDella Porta GPierotti MA. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. Journal of Clinical Investigation1993911753\u20131760. (https:\/\/doi.org\/10.1172\/JCI116385)10.1172\/JCI116385"},{"key":"bib98","series-title":"Cancer Research","first-page":"4710","article-title":"Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors","volume":"57","author":"Dahia","year":"1997","unstructured":"Dahia PLMarsh DJZheng ZZedenius JKomminoth PFrisk TWallin GParsons RLongy MLarsson CSomatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Research1997574710\u20134713."},{"key":"bib99","series-title":"Clinical Cancer Research","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1158\/1078-0432.CCR-06-1125","article-title":"Genetic alterations and their relationship in the phosphatidylinositol 3-kinase\/akt pathway in thyroid cancer","volume":"13","author":"Xing","year":"2007","unstructured":"Xing MGenetic alterations and their relationship in the phosphatidylinositol 3-kinase\/akt pathway in thyroid cancer. Clinical Cancer Research2007131161\u20131170.10.1158\/1078-0432.CCR-06-1125"},{"key":"bib100","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1210\/jc.2006-2019","article-title":"High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase\/Akt pathway in thyroid tumors","volume":"92","author":"Wang","year":"2007","unstructured":"Wang YHou PYu HWang WJi MZhao SYan SSun XLiu DShi BHigh prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase\/Akt pathway in thyroid tumors. Journal of Clinical Endocrinology and Metabolism2007922387\u20132390. (https:\/\/doi.org\/10.1210\/jc.2006-2019)10.1210\/jc.2006-2019"},{"key":"bib101","series-title":"Nature Communications","first-page":"1","article-title":"The genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing","volume":"8","author":"Ye","year":"2017","unstructured":"Ye LZhou XHuang FWang WQi YXu HShu YShen LFei XXie JThe genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing. Nature Communications201781\u20138. (https:\/\/doi.org\/10.1038\/ncomms15533)"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/187\/3\/EJE-21-1293.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/downloadpdf\/journals\/eje\/187\/3\/EJE-21-1293.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/eje.bioscientifica.com\/downloadpdf\/journals\/eje\/187\/3\/EJE-21-1293.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T16:17:48Z","timestamp":1676391468000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/187\/3\/R41\/6972123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":101,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1530\/eje-21-1293","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]}}}